FDA Brief

Warning letters Drugs

FDA warning letter to

Imprimis Rx LLC

Issued Jun 30, 2022Posted Jul 19, 2022Division of Pharmaceutical Quality Operations IV

False & Misleading Claims/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.